Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Sparsentan in Incident IgA Nephropathy
2018-002012-27Phase 2Unknown
- Sponsor
- University of Leicester
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sparsentan in IgA nephropathy (IgAN), sponsored by University of Leicester. Status: unknown.
02
Drugs
sparsentan
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on 2018-002012-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002012-27.